FIELD: medicine.
SUBSTANCE: children are divided into 4 groups; the first group includes the children having the following symptoms: short period of breastfeeding in the medical history, frequently ill family members, no complications of respiratory infections, IgA from 0.7 to 1.1 mg/ml, IgG from 10.6 to 16.2 mg/ml; the second group: mother's gestosis during the pregnancy, threatening miscarriage in the medical history, frequent complications of respiratory diseases - sinusitis, otitis; alpha2-globulin from 9.4 to 11.8 g/l, gamma-globulin from 17.8 to 22.6 g/l, TNF-α from 8.7 to 10.1 pg/ml, IgG from 16.7 to 23.7 mg/ml, CD3+ from 51 to 56.2%, CD4+ from 27.2 to 29.4%, CD16+CD56+ from 6.5 to 8.5%, nitro blue tetrazolium reduction test from 25 to 32.8%; the third group: mother's anaemia during the pregnancy, child's positive endocrine heredity, respiratory diseases frequently complicated with bronchitis, Candida seeding in throat swabs, gamma globulins from 12.1 to 14.9 g/l, IgG from 10.9 to 15.5 mg/ml, CD19+ from 7.6 to 9.6%, nitro blue tetrazolium reduction test from 25.5 to 31.7%; the fourth group: allergic reactions in the child's medical history, positive allergic heredity, respiratory diseases frequently complicated with obstructive bronchitis, gamma globulins from 18.1 to 23.1 g/l, IgE from 67 to 261 IU/ml. Acute respiratory diseases are prevented by Multitabs, a vitamin mineral complex, and one of the immunocorrective preparations: in the first group with IRS-19, a preparation of bacterial lysates; in the second group with a preparation of glucosaminyl muramyl dipeptide (Licopid); in the third group with a preparation of azoximer bromide (polyoxidonium); in the fourth group the immunocorrection is not recommended.
EFFECT: using the given method enables selecting a variant of immunocorrection depending on the presence or absence of diagnostic signs.
2 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR SELECTING APPROACH OF IMMUNOCORRECTING THERAPY FOR PREVENTING FREQUENT RESPIRATORY INFECTIONS IN PREADOLESCENT CHILDREN | 2020 |
|
RU2752746C1 |
METHOD FOR IMPROVING PSYCHOEMOTIONAL CHARACTERISTICS IN FREQUENTLY ILL PRIMARY SCHOOL-AGED CHILDREN | 2013 |
|
RU2535161C1 |
METHOD FOR PREVENTION OF REDUCED POSTVACCINAL HUMORAL IMMUNITY TO DIPHTHERIA AND PERTUSSIS IN SCHOOLCHILDREN OF 7-12 YEARS OLD, ASSOCIATED WITH UNFAVOURABLE ENVIRONMENTAL FACTORS | 2024 |
|
RU2826768C1 |
METHOD OF REHABILITATING SICKLY CHILDREN | 2010 |
|
RU2462220C2 |
METHOD OF TREATING AND PREVENTING CHRONIC INFLAMMATORY DISEASES OF NASOPHARYNX ASSOCIATED WITH INHALATION EXPOSURE TO BENZENE AND FORMALDEHYDE IN CHILDREN | 2016 |
|
RU2618469C1 |
METHOD FOR DRUG-INDUCED AND DRUG-FREE CORRECTION OF HEALTH STATUS OF SCHOOLCHILDREN WITH ALLERGIC DISEASES ASSOCIATED WITH COMPLEX EFFECT OF ENVIRONMENTAL FACTORS, LIFESTYLE FEATURES AND DISTURBED STRUCTURE OF SCHOOL MEALS | 2024 |
|
RU2826715C1 |
METHOD FOR SANITATION OF GERM CARRIER RESPIRATORY WAY | 2003 |
|
RU2257223C2 |
METHOD FOR PREVENTING VARIABLE IMMUNODEFICIENCY WITH PREDOMINANT VARIANCE OF B-CELL COUNT AND FUNCTIONAL ACTIVITY IN CHILDREN OF THREE YEARS AND MORE USING DRINKING WATER WITH RESIDUAL AMOUNT OF HYPERCHLORINATION PRODUCTS | 2014 |
|
RU2568853C1 |
METHOD FOR REHABILITATION OF INFANTILE CEREBRAL PARALYSIS (ICP) DISABLED CHILDREN WITH INFECTION BACKGROUND | 2007 |
|
RU2331419C1 |
METHOD FOR PREPARING FOR MANTOUX TEST WITH 2 TE PPD-L | 2013 |
|
RU2549442C1 |
Authors
Dates
2015-05-20—Published
2014-04-22—Filed